Close

Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. PPG


Go back to Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
National Health Partners, Inc. (NYSE: HPR) Delayed: 4.73 --0 (-0%)
Previous Close $4.73    52 Week High $0.28 
Open $3.62    52 Week Low $0.25 
Day High $4.73    P/E N/A 
Day Low $4.73    EPS $-0.23 
Volume 3,248       

HORIZON PHARMA (NASDAQ: HZNP) Delayed: 116.30 --0 (-0%)
Previous Close $116.30    52 Week High $23.44 
Open $116.30    52 Week Low $13.06 
Day High $116.30    P/E N/A 
Day Low $116.30    EPS $-0.96 
Volume 152,279       

(NASDAQ: VIE) Delayed: 53.01 --0 (-0%)
Previous Close $53.01    52 Week High $ 
Open $6.62    52 Week Low $ 
Day High $53.01    P/E N/A 
Day Low $53.01    EPS $ 
Volume 44,222